MicroRNA-21 regulates prostaglandin E2 signaling pathway by targeting 15-hydroxyprostaglandin dehydrogenase in tongue squamous cell carcinoma
Open Access
- 25 August 2016
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 16 (1) , 1-11
Abstract
Oral tongue squamous cell carcinoma (OTSCC) is one of the most aggressive forms of head and neck/oral cancer (HNOC), and is a complex disease with extensive genetic and epigenetic defects, including microRNA deregulation. Identifying the deregulation of microRNA-mRNA regulatory modules (MRMs) is crucial for understanding the role of microRNA in OTSCC. A comprehensive bioinformatics analysis was performed to identify MRMs in HNOC by examining the correlation among differentially expressed microRNA and mRNA profiling datasets and integrating with 12 different sequence-based microRNA target prediction algorithms. Confirmation experiments were performed to further assess the correlation among MRMs using OTSCC patient samples and HNOC cell lines. Functional analyses were performed to validate one of the identified MRMs: miR-21-15-Hydroxyprostaglandin Dehydrogenase (HPGD) regulatory module. Our bioinformatics analysis revealed 53 MRMs that are deregulated in HNOC. Four high confidence MRMs were further defined by confirmation experiments using OTSCC patient samples and HNOC cell lines, including miR-21-HPGD regulatory module. HPGD is a known anti-tumorigenic effecter, and it regulates the tumorigenic actions of Prostaglandin E2 (PGE2) by converts PGE2 to its biologically inactive metabolite. Ectopic transfection of miR-21 reduced the expression of HPGD in OTSCC cell lines, and the direct targeting of the miR-21 to the HPGD mRNA was confirmed using a luciferase reporter gene assay. The PGE2-mediated upregulation of miR-21 was also confirmed which suggested the existence of a positive feed-forward loop that involves miR-21, HPGD and PGE2 in OTSCC cells that contribute to tumorigenesis. We identified a number of high-confidence MRMs in OTSCC, including miR-21-HPGD regulatory module, which may play an important role in the miR-21-HPGD-PGE2 feed-forward loop that contributes to tumorigenesis.Keywords
Funding Information
- National Cancer Institute (CA139596, CA171436)
- Prevent Cancer Foundation (Lilly USA Research Award in Cancer Prevention and Early Detection)
- UIC College of Dentistry (CMBOD Oral Cancer Research Program - seed grant)
- National Nature Science Foundation of China (NSFC81472523)
- National Nature Science Foundation of China (NSFC81272953)
- National Institute of Dental and Craniofacial Research (DE025926)
This publication has 62 references indexed in Scilit:
- MicroRNA-99 Family Targets AKT/mTOR Signaling Pathway in Dermal Wound HealingPLOS ONE, 2013
- Evaluating the MicroRNA Targeting Sites by Luciferase Reporter Gene Assay2012
- Monoacylglycerol Lipase Exerts Dual Control over Endocannabinoid and Fatty Acid Pathways to Support Prostate CancerChemistry & Biology, 2011
- A role for COX2-derived PGE2 and PGE2-receptor subtypes in head and neck squamous carcinoma cell proliferationOral Oncology, 2010
- Identification and experimental validation of G protein alpha inhibiting activity polypeptide 2 (GNAI2) as a microRNA-138 target in tongue squamous cell carcinomaHuman Genetics, 2010
- MicroRNA‐24 targeting RNA‐binding protein DND1 in tongue squamous cell carcinomaFEBS Letters, 2010
- Downregulation of the Rho GTPase signaling pathway is involved in the microRNA‐138‐mediated inhibition of cell migration and invasion in tongue squamous cell carcinomaInternational Journal of Cancer, 2010
- Eicosanoids and cancerNature Reviews Cancer, 2010
- MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell linesCancer Letters, 2009
- 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesisProceedings of the National Academy of Sciences, 2006